That’s because our manufacturing process is automated and performed in one enclosed piece of equipment. The only human involvement is the loading of the API into the machine. After that, our BFS technology takes over. BFS ensures that the drug is both compounded and packaged without any human contact, greatly reducing the risk of contamination and errors. The FDA states,
"The advantages of BFS processing are known to include rapid container closure processing and minimized aseptic interventions."1 We use the BFS process to produce IV bags, single-dose injectable drug vials, syringes (isolator filling) and unit- and multiple-dose ophthalmic drugs. You can follow the process on the diagram below.
1 https://www.fda.gov/downloads/Drugs/Guidances/ucm070342.pdf, page 50. Accessed December 1, 2017.